Spectral Medical Inc T.EDT

RE:RE:RE:RE:RE:EBITDA Multiples updated...

[mercedesman]

Well BSWild has returned after a short absense.

Your Oct 10 post "my last post until next years financing." - didn't age very well. You only lasted 17 days !

Good luck in knocking this thing down to the twenties (or lower) again. Much differnt set of circumstances this time around:

• much less tax loss selling could be triggered in an "up" year
• weakest hands left late 2021 (with a thanks to them, from me, for their shares)
• short term selling of shares by institutions, due to warrant pricing - not a thing this time around
• Dialco news looming
• possibility of enrolment increase news this fall (for reasons espoused by JK) -  this was not possible last fall with overrun ICU's
• different story when you have an Equity investment (via convertible debentures) by a strategic partner (that they are doing business with).

But, if by some miracle, you are proven correct, I will happily be buying with both hands once again.  Let's see if you can make that happen again.  I have some left-over cash to put to work.  My gut is that we will both miss the boat this time...with the difference being that I have a good core position already.

I do not believe that the FDA Estimate for Primary Trial Completion is the best or even a base case.  It's a placeholder date. If it proves to be correct then JK and CS have something to answer for  (and hopefully they forego their RSU rewards in that case).  However, even so, underlyiing assets are unchanged as to ultimate value IMO.

And Baxter Tranche # 2 = $ 250k???  Bwhahahahhahhahhahha !  (very weak FUD effort)

Cash infusions via SAMI sales, possible Dialco deal, Baxter, traditional lenders, etc. remain to be seen.  Not sure there will ever be another equity financing needed...but Yes I did not expect as many as we have had before the coming denouement (a combo of questionable Dec. making and unfortunate circumstances, I would say).

MM